Top Markets
Coin of the day
I'rom Group Co., Ltd. I'rom Group Co., Ltd.

I'rom Group Co., Ltd.

2372
株式のランク #17926
I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key... I'rom Group Co., Ltd. is a Japanese enterprise specializing in several key areas: pioneering advanced medical treatments, offering site management organization (SMO) services, acting as a contract research organization (CRO), and providing various forms of medical support. The company spearheads the creation of cutting-edge medical technologies, particularly in regenerative medicine and gene therapy, to combat conditions like obstructive arteriosclerosis, retinitis pigmentosa, and HIV/AIDS. Their innovative contributions include the Sendai virus vector and the CytoTune-iPS kit, designed for generating induced pluripotent stem cells. Furthermore, I'rom assists medical institutions with clinical trial execution and delivers extensive support for the development of novel drugs and medical equipment, with a focus on cancer, rare, and intractable diseases. The company also oversees the establishment and operation of clinic malls. Founded in Tokyo in 1997, it was formerly known as I'Rom Holdings Co., Ltd. until its name change in July 2015.
株価
$18.20
最終同期: 2025-05-09
時価総額
$220.35M
変化(1日)
-5.34%
変化(1年)
0.00%
JP
取引 I'rom Group Co., Ltd. (2372)

カテゴリー

I'rom Group Co., Ltd.(2372)の収益
Dec 2024 時点の収益 TTM: $119.61M
I'rom Group Co., Ltd. の最新の財務報告によると、現在の収益 (TTM) は $119.61M です。2023 年には $138.21M の収益があり、これは 2022 年の $128.89M と比較して 増加 です。収益とは、企業が商品やサービスの販売によって得る総所得です。利益とは異なり、費用は差し引かれません。
I'rom Group Co., Ltd. の収益履歴(2005 ~ 2026)
各年末の収益
収益 変化
2026 (TTM) $119.61M 2.05%
2024 $117.21M -15.20%
2023 $138.21M 7.24%
2022 $128.89M 10.61%
2021 $116.52M 18.27%
2020 $98.53M 3.39%
2019 $95.30M 17.45%
2018 $81.14M 84.82%
2017 $43.90M 20.07%
2016 $36.56M 6.08%
2015 $34.47M -11.37%
2014 $38.89M -45.34%
2013 $71.14M -46.43%
2012 $132.81M -21.31%
2011 $168.78M 14.16%
2010 $147.85M 0.49%
2009 $147.13M 6.89%
2008 $137.65M 9.43%
2007 $125.78M 16.35%
2006 $108.10M 100.44%
2005 $53.93M 0.00%
同業他社の収益